The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
To the best of our knowledge, data on the effects of synbiotic supplementation on markers of insulin metabolism and lipid concentrations in patients with gestational diabetes mellitus (GDM) are scarce. The aim of the current study was to determine the effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in GDM patients. In total, seventy patients with GDM aged 18–40 years were assigned to two groups – the synbiotic group (n 35) and the placebo group (n 35) – in this randomised, double-blind, placebo-controlled trial. Patients in the synbiotic group received a daily capsule that contained three viable and freeze-dried strains:Lactobacillus acidophilus,Lactobacillus casei and Bifidobacterium bifidum(2×10 9 colony-forming units/g each) plus 800 mg inulin for 6 weeks. Fasting blood samples were collected at the beginning and week 6 to quantify related markers. After 6 weeks of intervention, compared with the placebo, synbiotic supplementation led to a significant decrease in serum insulin levels (−1·5 (sd 5·9)v.+4·8 (sd 11·5) µIU/ml,P=0·005), homoeostatic model assessment for insulin resistance (−0·4 (sd 1·3)v.+1·1 (sd 2·7),P=0·003) and homoeostatic model assessment for β cell function (−5·1 (sd 24·2)v.+18·9 (sd 45·6),P=0·008) and a significant increase in quantitative insulin sensitivity check index (+0·01 (sd 0·01)v.−0·007 (sd 0·02),P=0·02). In addition, synbiotic intake significantly decreased serum TAG (−14·8 (sd 56·5)v.+30·4 (sd 37·8) mg/dl,P<0·001) and VLDL-cholesterol concentrations (−3·0 (sd 11·3)v.+6·1 (sd 7·6) mg/dl,P<0·001) compared with the placebo. Overall, the results of this study demonstrate that taking synbiotic supplements for 6 weeks among patients with GDM had beneficial effects on markers of insulin metabolism, TAG and VLDL-cholesterol concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Kling Bäckhed, H., Gonzalez, A., Werner, J. J., Angenent, L. T., Knight, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.008 · Cited by 2,165 · cited 1×
“associated with metabolic diseases including type 2 diabetes mellitus (T2DM), insulin resistance((3)) and increased inflammatory cytokines((4)).”
BackgroundBeneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709
Impact of consuming a milk drink containing a probiotic on mood and cognition
Benton, D., Williams, C., & Brown, A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602546 · Cited by 554
Schaefer-Graf, U. M., Graf, K., Kulbacka, I., Kjos, S. L., Dudenhausen, J., Vetter, K., & Herrera, E. (2008) · Diabetes Care · doi:10.2337/dc08-0039 · Cited by 439 · cited 1×
“Both increased maternal TAG and free fatty acid levels in GDM women correlated with fetal growth during pregnancy and with neonatal anthropometric measures((31)).”
BackgroundLimitations in the Use of Indices Using Glucose and Insulin Levels to Predict Insulin Sensitivity
Pisprasert, V., Ingram, K. H., Lopez-Davila, M. F., Munoz, A. J., & Garvey, W. T. (2013) · Diabetes Care · doi:10.2337/dc12-0840 · Cited by 302 · cited 1×
“The homoeostatic model assessment for insulin resistance (HOMA-IR), homoeostatic model assessment for B-cell function (HOMA-B) and the quantitative insulin sensitivity check index (QUICKI) were determined according to suggested formulae((18)).”
MethodRajkumar, H., Kumar, M., Das, N., Kumar, S. N., Challa, H. R., & Nagpal, R. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414555004 · Cited by 128
Asemi, Z., Samimi, M., Tabassi, Z., & Esmaillzadeh, A. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.296 · Cited by 119
Self-citation
Cited by
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Koutnikova, H., Genser, B., Monteiro-Sepulveda, M., Faurie, J.-M., Rizkalla, S., Schrezenmeir, J., & Clément, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2017-017995 · Cited by 299
Zhou, L., Ding, C., Wu, J., Chen, X., Ng, D. M., Wang, H., Zhang, Y., & Shi, N. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.08.005 · Cited by 53
Parker, J., O'Brien, C., & Hawrelak, J. (2022) · Obstetrics & Gynecology Science · doi:10.5468/ogs.21185 · Cited by 42
“As a class of agents, synbiotics have a growing evidence base for the treatment of obesity [106], gestational diabetes [107], type 1 [108], and type 2 diabetes [109].”
BackgroundCao, D. X., Wong, E. Y., Vela, M. N., & Le, Q. T. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000518677 · Cited by 18
Metadata
- Authors
- Ahmadi, S., Jamilian, M., Tajabadi-Ebrahimi, M., Jafari, P., & Asemi, Z.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2016-09-29
- Volume
- 116
- Issue
- 8
- Pages
- 1394-1401
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2524691406
- Cited by
- 75
- References
- 8
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1017/s0007114516003457
- The paper
- Ahmadi, S., Jamilian, M., Tajabadi-Ebrahimi, M., Jafari, P., & Asemi, Z. (2016). The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition. https://doi.org/10.1017/s0007114516003457
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.